Serum Permeability Activity in Steroid-Resistant Minimal Change Nephrotic Syndrome Is Abolished by Treatment of Hodgkin Disease

American Journal of Kidney Diseases

Volumn 50, Issue 5, 2007, Pages 826-829

  Aggarwal, Nidhi ^a   Batwara, Ruchika ^a   McCarthy, Ellen T ^b   Sharma, Ram ^c   Sharma, Mukut ^a   Savin, Virginia J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c Kansas City Veterans Affairs   (United States)

Author keywords

Hodgkin disease; nephrotic syndrome; Permeability activity

Indexed keywords

BLEOMYCIN; CYCLOSPORIN A; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROTEIN; VINBLASTINE;

ADULT; ARTICLE; BLOOD PRESSURE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CASE REPORT; DRUG DOSE REDUCTION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; LABORATORY TEST; MALE; NEPHROTIC SYNDROME; PERMEABILITY; PHYSICAL EXAMINATION; PROTEINURIA; REMISSION; SERUM;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMORBIDITY; CYCLOSPORINE; GLOMERULAR FILTRATION RATE; HODGKIN DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY GLOMERULUS; MALE; NEPHROSIS, LIPOID; PERMEABILITY; REMISSION INDUCTION;

EID: 35348880265     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.06.021     Document Type: Article

References (19)

1. Trachtman H., Greenbaum L.A., McCarthy E.T., et al. Glomerular permeability activity: Prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome. Am J Kidney Dis 44 (2004) 604-610
2. Savin V.J., Sharma R., Sharma M., et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334 (1996) 878-883
3. Savin V.J., McCarthy E.T., and Sharma M. Permeability factors in focal segmental glomerosclerosis. Semin Nephrol 23 (2003) 147-160
4. Pudur S., Savin V.J., McCarthy E.T., and Sharma M. Albumin permeability (Palb) in focal segmental glomerulosclerosis (FSGS) is associated with rapid progression to end-stage renal disease (ESRD). National Kidney Foundation 2006 Spring Clinical Meetings Abstracts, April 19-23, 2006, Chicago, IL. Am J Kidney Dis 47 (2006) B1-B18
5. Sharma R., Sharma M., McCarthy E.T., Ge X., and Savin V.J. Components of normal serum block the focal segmental glomerulosclerosis factor activity in vitro. Kidney Int 58 (2000) 1973-1979
6. Candiano G., Musante L., Carroaro M., et al. Apolipoproteins prevent glomerular albumin permeability induced in vitro by serum from patients with focal segmental glomerulosclerosis. J Am Soc Nephrol 12 (2001) 143-150
7. Mallouk A., Pham P.T., and Pham P.C. Concurrent FSGS and Hodgkin's lymphoma: Case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies. Clin Exp Nephrol 10 (2006) 284-289
8. Moorthy A.V., Zimmerman S.W., and Burkholder P.M. Nephrotic syndrome in Hodgkin's disease. Evidence for pathogenesis alternative to immune complex deposition. Am J Med 61 (1976) 471-477
9. Savin V.J., Sharma R., Lovell H.B., and Welling D.J. Measurement of albumin reflection coefficient with isolated rat glomeruli. J Am Soc Nephrol 3 (1992) 1260-1269
10. McCarthy E.T., Sharma M., Sharma R., Falk R.J., and Jennette J.C. Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli. J Lab Clin Med 143 (2004) 225-229
11. Orth S.R., and Ritz E. The nephrotic syndrome. N Engl J Med 338 (1998) 1202-1211
12. Shalhoub R.J. Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 2 (1974) 556-560
13. Sharma M., Sharma R., McCarthy E.T., and Savin V.J. The focal segmental glomerulosclerosis permeability factor: Biochemical characteristics and biological effects. Exp Biol Med (Maywood) 229 (2004) 85-98
14. Artero M.L., Sharma R., Savin V.J., and Vincenti F. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 23 (1994) 574-581
15. Dilek I., Demir C., Ustun Y., and Erkoc R. Microalbuminuria in Hodgkin's disease. Int J Clin Pract 59 (2005) 330-332
16. Dabbs D.J., Striker L.M., Mignon F., and Striker G. Glomerular lesions in lymphomas and leukemias. Am J Med 80 (1986) 63-70
17. Sherman R.L., Susin M., Weksler M.E., and Becker E.L. Lipoid nephrosis in Hodgkin's disease. Am J Med 52 (1972) 699-706
18. Delmez J.A., Safdar S.H., and Kissane J.M. The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease. Am J Kidney Dis 23 (1994) 743-746
19. Cattran D., Neogi T., Sharma R., McCarthy E.T., and Savin V.J. Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis. J Am Soc Nephrol 14 (2003) 448-453